TY - JOUR
T1 - Canadian Pediatric Neuro-Oncology Standards of Practice
AU - Bennett, Julie
AU - Erker, Craig
AU - Lafay-Cousin, Lucie
AU - Ramaswamy, Vijay
AU - Hukin, Juliette
AU - Vanan, Magimairajan I.
AU - Cheng, Sylvia
AU - Coltin, Hallie
AU - Fonseca, Adriana
AU - Johnston, Donna
AU - Lo, Andrea
AU - Zelcer, Shayna
AU - Alvi, Saima
AU - Bowes, Lynette
AU - Brossard, Josée
AU - Charlebois, Janie
AU - Eisenstat, David
AU - Felton, Kathleen
AU - Fleming, Adam
AU - Jabado, Nada
AU - Larouche, Valérie
AU - Legault, Geneviève
AU - Mpofu, Chris
AU - Perreault, Sébastien
AU - Silva, Mariana
AU - Sinha, Roona
AU - Strother, Doug
AU - Tsang, Derek S.
AU - Wilson, Beverly
AU - Crooks, Bruce
AU - Bartels, Ute
N1 - Publisher Copyright:
© Copyright © 2020 Bennett, Erker, Lafay-Cousin, Ramaswamy, Hukin, Vanan, Cheng, Coltin, Fonseca, Johnston, Lo, Zelcer, Alvi, Bowes, Brossard, Charlebois, Eisenstat, Felton, Fleming, Jabado, Larouche, Legault, Mpofu, Perreault, Silva, Sinha, Strother, Tsang, Wilson, Crooks and Bartels.
PY - 2020/12/22
Y1 - 2020/12/22
N2 - Primary CNS tumors are the leading cause of cancer-related death in pediatrics. It is essential to understand treatment trends to interpret national survival data. In Canada, children with CNS tumors are treated at one of 16 tertiary care centers. We surveyed pediatric neuro-oncologists to create a national standard of practice to be used in the absence of a clinical trial for seven of the most prevalent brain tumors in children. This allowed description of practice across the country, along with a consensus. This had a multitude of benefits, including understanding practice patterns, allowing for a basis to compare in future research and informing Health Canada of the current management of patients. This also allows all children in Canada to receive equivalent care, regardless of location.
AB - Primary CNS tumors are the leading cause of cancer-related death in pediatrics. It is essential to understand treatment trends to interpret national survival data. In Canada, children with CNS tumors are treated at one of 16 tertiary care centers. We surveyed pediatric neuro-oncologists to create a national standard of practice to be used in the absence of a clinical trial for seven of the most prevalent brain tumors in children. This allowed description of practice across the country, along with a consensus. This had a multitude of benefits, including understanding practice patterns, allowing for a basis to compare in future research and informing Health Canada of the current management of patients. This also allows all children in Canada to receive equivalent care, regardless of location.
UR - http://www.scopus.com/inward/record.url?scp=85099028476&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099028476&partnerID=8YFLogxK
U2 - 10.3389/fonc.2020.593192
DO - 10.3389/fonc.2020.593192
M3 - Article
AN - SCOPUS:85099028476
SN - 2234-943X
VL - 10
JO - Frontiers in Oncology
JF - Frontiers in Oncology
M1 - 593192
ER -